Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fully-connected microwave photonic multi-beamformer with fast beam-steering for broadband wireless communication.

Nature communications·2026

Same author

Integrated network toxicology and transcriptomics reveal NF-κB signaling as a key mediator of TDCPP-induced inflammatory responses in human microglia.

Environment international·2026

Same author

EZH2 deficiency suppresses colorectal cancer progression by inhibiting the mismatch repair pathway and consequently reducing extrachromosomal circular DNA formation.

Cell death & disease·2026

Same author

CD36 aggravates ferroptosis in NK cells and dampens their anti-fibrotic activity in the liver.

Frontiers in immunology·2026

Same author

Lubricin in osteoarthritis: functions and therapeutic prospects.

Frontiers in immunology·2026

Same author

Mechanistic insights into BDE-153-induced idiopathic pulmonary fibrosis through network toxicology, machine learning, and cellular validation.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026

Search research articles

Related Experiment Video

Updated: May 3, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

[Research on tumor information grid framework].

Haowei Zhang¹, Zhu Qin², Ying Liu²

¹College of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China. howiezh@sina.com

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi

|January 28, 2014

Summary

This summary is machine-generated.

This study introduces a tumor grid framework for sharing and managing cancer data across institutions. It enhances interoperability and resource accessibility for improved medical research and patient care.

More Related Videos

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

Related Experiment Videos

Last Updated: May 3, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

Area of Science:

Bioinformatics
Health Informatics
Grid Computing

Context:

Tumor disease information sharing and management are fragmented across medical institutions.
Heterogeneous data and software resources lack interoperability.
Need for a unified framework for collaborative cancer research.

Purpose:

To develop a tumor grid framework for effective integration and interoperability of distributed tumor data and software resources.
To enable semantic and syntactic consistency across heterogeneous medical data.
To establish a multi-center, large-sample, networking framework for tumor disease resource sharing.

Summary:

Utilized grid technology to integrate distributed tumor data and software resources from various medical institutions.
Employed Web Service Description Language (WSDL) and extensible markup language schemas definition (XSD) for service packaging.
Implemented Web Services Resource Framework (WSRF) for resource registration and release, enabling client access via serialized documents.
Service objects built using Unified Modeling Language (UML) as middleware for Application Programming Interface (API) creation.

Impact:

Facilitates a multi-center, large-sample, networking framework for tumor disease resource sharing.
Improves the development level of medical scientific research institutions.
Enhances the quality of life for patients through better data management and research outcomes.